AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer (Q113889826)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer |
clinical trial |
Statements
A Randomized Phase 2 Trial to Assess the Efficacy of AT in Comparison to TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer : Evaluating the Homologous Recombination Deficiency(HRD) Biomarker (English)
0 references
August 2020
0 references
August 2021
0 references
100
0 references
18 year
0 references